Agios Therapeutics: HC Wainwright Raises PT to $65, Maintains Buy Rating

jueves, 12 de febrero de 2026, 2:18 pm ET1 min de lectura
AGIO--

Agios Therapeutics: HC Wainwright Raises PT to $65, Maintains Buy Rating

Agios Therapeutics: HC Wainwright Raises PT to $65, Maintains Buy Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios